FDA Clearance Tracker · K243463
BIOFIRE FILMARRAY Tropical Fever Panel
Last checked: Nov 19, 2026Latest source record: Dec 5, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 5, 2024
Substantially Equivalent
Time to decision
27 days
Received Nov 8, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243463
- Device name
- BIOFIRE FILMARRAY Tropical Fever Panel
- Applicant location
- Salt Lake City, UT
- Received
- Nov 8, 2024
- Decided
- Dec 5, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Device To Detect And Identify Selected Microbial Agents That Cause Acute Febrile Illness (QMV)
- Device class
- Class II
- Regulation
- 21 CFR 866.3966
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QMV. The earliest in FDA's data is DEN200043, decided Nov 20, 2020.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243463
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Biofire Diagnostics, LLC (Biomerieux)
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243222 · Decided Nov 6, 2024 · 30 days after receipt
Device type: Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System (QDS) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.